RESPIRATORY
CYSTIC FIBROSIS
|
Question
[CLICK ON ANY CHOICE TO KNOW THE RIGHT ANSWER]
|
What is the nucleotide mutation?
|
|
exon 3
|
|
|
exon 19
|
|
|
exon 4
|
|
|
exon 13
|
Explanation:
Detailed explanation-1: -KIT Exon 13 Mutation is a predictive biomarker for use of imatinib in patients. Of the therapies with KIT Exon 13 Mutation as a predictive biomarker, 1 has NCCN guidelines in at least one clinical setting. Melanoma has the most therapies targeted against KIT Exon 13 Mutation or its related pathways [5].
There is 1 question to complete.